Name | Ziprasidone Hydrochloride Monohydrate | CAS# | 138982-67-9 | |
---|---|---|---|---|
Price | ¥Inquiry/1g | Purity | 98.9% | |
Stocking Period |
1 Day | Stock | In Stock |
Detail
Product Information
Ziprazidone is approved for the treatment of schizophrenia, and acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in schizophrenic patients for whom treatment with just ziprasidone is appropriate. The mechanism of action of ziprasidone, as with other drugs having efficacy in schizophrenia, is unknown. However, it has been proposed that this drug's efficacy in schizophrenia is mediated through a combination of dopamine type 2 (D2) and serotonin type 2 (5HT2) antagonism. As with other drugs having efficacy in bipolar disorder, the mechanism of action of ziprasidone in bipolar disorder is unknown. |
Get all suppliers by the below link:
Ziprasidone Hydrochloride Monohydrate suppliers
2024-07-15 |
Ziprasidone Hydrochloride Monohydrate
Price: Inquiry |
2020-12-18 |
Ziprasidone HCl hydrate
Price: $Inquiry |
2021-07-26 |
Ziprasidone hydrochloride
Price: $Inquiry |
2024-01-09 |
138982-67-9 5-[2-[4-(1,2-Benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride
Price: $Inquiry |
2017-07-11 |
Ziprasidone Hydrochloride Monohydrate
Price: ¥Inquiry |
2022-05-12 |
Ziprasidone hydrochloride monohydrate
Price: $Inquiry |
2017-12-18 |
Ziprasidone Hydrochloride Monohydrate
Price: ¥Inquiry |
2021-02-06 |
Ziprasidone hydrochloride monohydrate
Price: ¥989.0 |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved